Repligen Corp. (RGEN)
176.27
-5.76
(-3.16%)
USD |
NASDAQ |
Aug 28, 16:00
176.25
-0.02
(-0.01%)
After-Hours: 20:00
Repligen Free Cash Flow : 110.15M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 110.15M |
| March 31, 2026 | 104.46M |
| December 31, 2025 | 91.69M |
| September 30, 2025 | 103.47M |
| June 30, 2025 | 102.94M |
| March 31, 2025 | 116.73M |
| December 31, 2024 | 142.49M |
| September 30, 2024 | 131.26M |
| June 30, 2024 | 119.26M |
| March 31, 2024 | 109.54M |
| December 31, 2023 | 74.93M |
| September 30, 2023 | 97.48M |
| June 30, 2023 | 51.15M |
| March 31, 2023 | 45.58M |
| December 31, 2022 | 38.74M |
| September 30, 2022 | 14.50M |
| June 30, 2022 | 41.48M |
| March 31, 2022 | 42.43M |
| December 31, 2021 | 47.74M |
| September 30, 2021 | 34.66M |
| June 30, 2021 | 40.18M |
| March 31, 2021 | 31.98M |
| December 31, 2020 | 36.28M |
| September 30, 2020 | 43.66M |
| June 30, 2020 | 42.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 42.60M |
| December 31, 2019 | 44.06M |
| September 30, 2019 | 34.85M |
| June 30, 2019 | 35.31M |
| March 31, 2019 | 25.94M |
| December 31, 2018 | 19.99M |
| September 30, 2018 | 32.08M |
| June 30, 2018 | 13.84M |
| March 31, 2018 | 12.15M |
| December 31, 2017 | 12.00M |
| September 30, 2017 | -0.362M |
| June 30, 2017 | -0.866M |
| March 31, 2017 | 7.29M |
| December 31, 2016 | 3.196M |
| September 30, 2016 | 4.884M |
| June 30, 2016 | 14.40M |
| March 31, 2016 | 11.76M |
| December 31, 2015 | 12.42M |
| September 30, 2015 | 8.761M |
| June 30, 2015 | 7.079M |
| March 31, 2015 | 1.821M |
| December 31, 2014 | 12.80M |
| September 30, 2014 | 20.16M |
| June 30, 2014 | 19.11M |
| March 31, 2014 | 25.42M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioLife Solutions, Inc. | 7.987M |
| Danaher Corp. | 5.466B |
| Liquidia Corp. | 150.69M |
| Harmony Biosciences Holdings, Inc. | 335.65M |
| Agilent Technologies, Inc. | 1.267B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 32.77M |
| Cash from Investing (Quarterly) | -2.089M |
| Cash from Financing (Quarterly) | -6.20M |
| Free Cash Flow Per Share (Quarterly) | 0.4714 |
| Free Cash Flow to Equity (Quarterly) | 23.38M |
| Free Cash Flow to Firm (Quarterly) | 28.85M |
| Free Cash Flow Yield | 1.10% |